Posts

Showing posts with the label commercialization

Breaking Barriers: TECELRA Becomes the First Engineered T-Cell Therapy for Solid Tumors

Fabhalta: aprendizajes para el desarrollo exitoso de fármacos en enfermedades raras

Fabhalta: learnings for successful drug development in rare diseases